| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/10/2011 | CN102145128A Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
| 08/10/2011 | CN102145076A Rehmannia and new use of extract of rehmannia |
| 08/10/2011 | CN102145072A Traditional Chinese medicine composition for treating infantile eczema and dermatitis skin diseases |
| 08/10/2011 | CN102145061A Qidan nasal allergy medicament and preparation method thereof |
| 08/10/2011 | CN102145030A Kiwi soft capsule preparation method with functions of regulating immunity and inhibiting tumors |
| 08/10/2011 | CN102145029A Lycopene-containing tablets and preparation method thereof |
| 08/10/2011 | CN102145024A Fungal composition with effect of enhancing immunity and preparation method thereof |
| 08/10/2011 | CN102145022A Lucid ganoderma composition with effects of enhancing immunity and resisting radiation and preparation method thereof |
| 08/10/2011 | CN102145019A Medicinal composition containing truffles, vitamins and mineral substances |
| 08/10/2011 | CN102145016A Pharmaceutical composition containing vitamins and minerals |
| 08/10/2011 | CN102145015A Asterias amurensis amylase extractive and applications thereof |
| 08/10/2011 | CN102145013A Method for preparing liposome solution of chicken spleen transfer factor |
| 08/10/2011 | CN101940694B Medicament for regulating sub-health of human body |
| 08/10/2011 | CN101850057B Vital nourishing ant wine and preparation method thereof |
| 08/10/2011 | CN101797298B Ointment for treating eczema and preparation method thereof |
| 08/10/2011 | CN101708193B Pharmaceutical composition of triptolide-containing medicine and bracken and preparation and application thereof |
| 08/10/2011 | CN101590070B Use of baicalin in preparation of targeted organ protection medicaments |
| 08/10/2011 | CN101423558B Eupatorium adenophorum spreng polysaccharide and preparation method and use |
| 08/10/2011 | CN101415702B Hetero compound |
| 08/10/2011 | CN101411864B Thymopentin dry powder formulation and preparation method thereof |
| 08/10/2011 | CN101394868B Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 08/10/2011 | CN101351466B Heterocyclic Janus kinase 3 inhibitors |
| 08/10/2011 | CN101333255B BP180 single chain antibody of humanized anti-bullous pemphigoid antigen and its use |
| 08/10/2011 | CN101259233B Traditional Chinese medicine preparation for improving adult chicken immunity and antioxidant ability |
| 08/10/2011 | CN101085802B Method for preparing Notoginsen triterpenes |
| 08/10/2011 | CN101054408B Method for separating housefly secretion type antibacterial peptide, product and application thereof |
| 08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994292 MU-1, member of the cytokine receptor family |
| 08/09/2011 | US7994289 Humanized anti-CD3 antibodies |
| 08/09/2011 | US7994288 Allergenic proteins of natural rubber latex, their production and use in assays |
| 08/09/2011 | US7994282 Card proteins involved in cell death regulation |
| 08/09/2011 | US7994214 Solid dispersions comprising tacrolimus |
| 08/09/2011 | US7994188 Compounds for treating inflammatory diseases |
| 08/09/2011 | US7994159 inhibits proliferation of c-Kit kinase activated-cancer; also mastocytosis, allergy and asthma, which are considered to be caused by c-Kit kinase; 4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
| 08/09/2011 | US7994146 Method of enhancing an immune response |
| 08/09/2011 | US7994137 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
| 08/09/2011 | US7994096 Method for antigen-specific stimulation of T lymphocytes with synthetic peptide libraries |
| 08/09/2011 | US7993878 Antibodies to human IL-1β |
| 08/09/2011 | US7993641 Methods of treatment using anti-CD3 antibodies |
| 08/09/2011 | DE202011004855U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von Erkrankungen Medicinal or dietary supplement for the treatment and / or prophylaxis of diseases |
| 08/09/2011 | CA2572208C 3-carbamoyl-2-pyridone derivative |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2445190C Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2405958C Hybrid glycosylated products and their production and use |
| 08/09/2011 | CA2350340C B-cell epitopes of hsp65 and uses thereof |
| 08/09/2011 | CA2302809C Membrane virus host range mutations and their uses as vaccine substrates |
| 08/09/2011 | CA2243559C Pharmaceutical composition for immunomodulation |
| 08/09/2011 | CA2237995C Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 08/09/2011 | CA2146328C C-c ckr-1, c-c chemokine receptor |
| 08/04/2011 | WO2011094598A2 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 08/04/2011 | WO2011094465A1 Methods of treating autoimmune diseases with dll4 antagonists |
| 08/04/2011 | WO2011094426A1 Caspase inhibitors |
| 08/04/2011 | WO2011094288A1 Pyrazolopyrazine kinase inhibitors |
| 08/04/2011 | WO2011094283A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011094273A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | WO2011094259A2 Cd127 binding proteins |
| 08/04/2011 | WO2011094008A1 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| 08/04/2011 | WO2011093469A1 Expression promoter for redox-related factor |
| 08/04/2011 | WO2011093290A1 Anti-inflammatory agent |
| 08/04/2011 | WO2011092695A1 Quinazoline-based t cell proliferation inhibitors |
| 08/04/2011 | WO2011092294A1 Extracellular ifi16 as therapeutic agents |
| 08/04/2011 | WO2011092187A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | WO2011092140A1 Pyrazole compounds as crth2 antagonists |
| 08/04/2011 | WO2011091973A1 5-nitro-8-hydroxyquinolines as inhibitors of cathepsin b |
| 08/04/2011 | WO2011091719A1 Crystalline hydrates of alkyl acyl acetaldehyde sulfite, preparation methods and uses thereof |
| 08/04/2011 | US20110191915 Influenza virus immunizing epitope |
| 08/04/2011 | US20110191869 Method For Characterising The Biological Activity Of Helminth Eggs, In Particular Trichuris Eggs |
| 08/04/2011 | US20110191865 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/04/2011 | US20110190623 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy |
| 08/04/2011 | US20110190398 Use of immunosuppressant compounds in a new indication |
| 08/04/2011 | US20110190366 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| 08/04/2011 | US20110190336 Azabenzimidazolones |
| 08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
| 08/04/2011 | US20110190318 Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 08/04/2011 | US20110190303 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190260 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/04/2011 | US20110190259 Compounds and compositions as protein kinase inhibitors |
| 08/04/2011 | US20110190258 Aryl benzylamine compounds |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190255 Heterocyclic compounds |
| 08/04/2011 | US20110190248 Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/04/2011 | US20110190239 Bmi-1 protein expression modulators |
| 08/04/2011 | US20110190230 Betalain Compositions and Uses Thereof |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110190211 Cyclopentaquinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 08/04/2011 | US20110190203 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 08/04/2011 | US20110189318 Methods for enhancing the expression of intracellular redox-associated factors |
| 08/04/2011 | US20110189299 Pharmaceutical composition containing surface-coated microparticles |
| 08/04/2011 | US20110189268 Inhibition of Placenta Growth Factor (PLGF) Mediated Metastasis and/or Angiogenesis |
| 08/04/2011 | US20110189267 MULTIPLE CpG OLIGODEOXYNUCLEOTIDE AND THEIR USE TO INDUCE AN IMMUNE RESPONSE |
| 08/04/2011 | US20110189262 Methods and Compositions for Reducing Systemic Toxicity of Vectors |
| 08/04/2011 | US20110189237 Therapeutic Agent for Malignant Mesothelioma and Immunostimulant |
| 08/04/2011 | US20110189236 Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria |
| 08/04/2011 | US20110189235 Adipogenic Adenoviruses As A Biomarker For Disease |
| 08/04/2011 | US20110189234 Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles |
| 08/04/2011 | US20110189233 Recombinant Varicella-Zoster Virus |